BMI Definition of Obesity
A BMI of ≥30 kg/m² defines obesity in adults in North America, Europe, sub-Saharan Africa, the Middle East, and Australia, with further classification into Class I (30-34.9 kg/m²), Class II (35-39.9 kg/m²), and Class III (≥40 kg/m²). 1
Standard BMI Classification
The most recent 2025 AACE consensus statement provides the following weight categories based on BMI:
- Overweight: BMI 25.0-29.9 kg/m²
- Class I Obesity: BMI 30.0-34.9 kg/m²
- Class II Obesity: BMI 35.0-39.9 kg/m²
- Class III Obesity: BMI ≥40.0 kg/m²
These cutoffs are recommended by the World Health Organization and are operative across most Western populations. 1
Critical Ethnic Variations
BMI thresholds must be adjusted downward for Asian populations because cardiometabolic disease risk occurs at significantly lower BMI levels in these groups. 1
Asia-Pacific Region Cutoffs:
- India, South Korea, Japan: Obesity defined as BMI ≥25.0 kg/m² (overweight: 23.0-24.9 kg/m²)
- China: Obesity defined as BMI ≥28.0 kg/m² (overweight: 24.0-27.9 kg/m²)
- South and Central American older adults: Obesity cutoff of 27.2 kg/m² has been recommended 1
Important Clinical Caveats
BMI alone is insufficient for diagnosing obesity-related health risk. Physical examination must confirm excess adiposity, as BMI can be misleading in several populations:
- Overestimates adiposity in: Muscular athletes, individuals with high lean body mass
- Underestimates adiposity in: Frail or elderly individuals, those with sarcopenic obesity (low BMI but excess fat), individuals with edema or fluid retention 1
Additional Assessment Required:
Beyond BMI, measure waist circumference to assess central adiposity and cardiometabolic risk:
- US/Canada: ≥102 cm (men), ≥88 cm (women)
- Europe/Middle East/sub-Saharan Africa: ≥94 cm (men), ≥80 cm (women)
- East/South Asia: ≥90 cm (men), ≥80 cm (women) 1
Waist-to-height ratio ≥0.5 is a superior indicator of cardiovascular disease risk across all populations and should be used alongside BMI. 1
Limitations of BMI as Sole Diagnostic Tool
The 2025 AACE guideline emphasizes that BMI does not indicate the impact of excess adiposity on overall health—it merely screens for excess weight. 2 The health consequences of obesity (diabetes, hypertension, cardiovascular disease, sleep apnea) determine actual disease severity and treatment urgency, not BMI alone. 2, 1
Research demonstrates that BMI-defined obesity (≥30 kg/m²) has high specificity (95-99%) but poor sensitivity (36-49%) for detecting body fat percentage-defined obesity, missing more than half of individuals with excess adiposity. 3 In one analysis, 36% of individuals with metabolic syndrome would not qualify for obesity treatment using BMI thresholds alone. 4
Clinical interpretation must consider: age, sex, muscularity, fluid status, presence of sarcopenia, and osteopenia risk before making treatment decisions based solely on BMI values. 1